|
WO1997028149A1
(en)
|
1996-02-02 |
1997-08-07 |
Merck & Co., Inc. |
Method for raising hdl cholesterol levels
|
|
US5663415A
(en)
|
1996-06-28 |
1997-09-02 |
Jame Fine Chemicals, Inc. |
Process for preparing antihistamine tannates
|
|
AR008789A1
(es)
|
1996-07-31 |
2000-02-23 |
Bayer Corp |
Piridinas y bifenilos substituidos
|
|
US6613942B1
(en)
|
1997-07-01 |
2003-09-02 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
BR9810378A
(pt)
|
1997-07-01 |
2000-08-29 |
Novo Nordisk As |
Composto,uso do mesmo, composição farmacêutica, e, processos de tratar a diabete do tipo i ou do tipo ii, de tratar a hiperglicemia, e de diminuir a glicose do sangue em um mamìfero
|
|
WO2000042026A1
(en)
|
1999-01-15 |
2000-07-20 |
Novo Nordisk A/S |
Non-peptide glp-1 agonists
|
|
DE60023492T2
(de)
|
1999-05-17 |
2006-07-20 |
Novo Nordisk A/S |
Glucagon antagonisten/inverse agonisten
|
|
CA2379604A1
(en)
|
1999-09-28 |
2001-04-05 |
Bayer Corporation |
Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use
|
|
US6881741B2
(en)
|
2001-06-11 |
2005-04-19 |
Virochem Pharma Inc. |
Compounds and methods for the treatment or prevention of Flavivirus infections
|
|
UA74912C2
(en)
*
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
|
US20030083354A1
(en)
|
2001-10-26 |
2003-05-01 |
Pediamed Pharmaceuticals, Inc. |
Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
|
|
US6670370B1
(en)
|
2001-12-14 |
2003-12-30 |
Jame Fine Chemicals, Inc. |
Dextromethorphan tannate
|
|
US20030114535A1
(en)
|
2001-12-14 |
2003-06-19 |
Jame Fine Chemicals, Inc. |
Dextrochlorpheniramine tannate
|
|
JO2625B1
(en)
*
|
2003-06-24 |
2011-11-01 |
ميرك شارب اند دوم كوربوريشن |
Phosphoric acid salts of dipeptidyl betidase inhibitor 4
|
|
JP2007504230A
(ja)
|
2003-09-02 |
2007-03-01 |
メルク エンド カムパニー インコーポレーテッド |
ジペプチジルペプチダーゼ−ｉｖ阻害剤のリン酸塩の新規結晶性形態
|
|
EP1667524A4
(en)
|
2003-09-23 |
2009-01-14 |
Merck & Co Inc |
NEW CRYSTALLINE FORM OF A PHOSPHORIC ACID SALT OF A DIPEPTIDYLPEPTIDASE IV INHIBITOR
|
|
US20080227786A1
(en)
|
2004-01-16 |
2008-09-18 |
Ferlita Russell R |
Novel Crystalline Salts of a Dipeptidyl Peptidase-IV Inhibitor
|
|
US20050202050A1
(en)
*
|
2004-03-12 |
2005-09-15 |
Kiel Jeffrey S. |
Single tank process for preparing tannate liquid and semi-solid dosage forms
|
|
EP1796671A4
(en)
|
2004-09-15 |
2009-01-21 |
Merck & Co Inc |
AMORPHIC FORM OF A PHOSPHORIC ACID SALT OF A DIPEPTIDYL-PEPTIDASE IV HEMMER
|
|
US20060270722A1
(en)
*
|
2005-05-31 |
2006-11-30 |
Thornberry Nancy A |
Combination of a dipeptidyl peptidase-IV inhibitor and a dual PPAR agonist for the treatment of diabetes and obesity
|
|
US20090221592A1
(en)
*
|
2005-07-25 |
2009-09-03 |
Ellison Martha E |
Dodecylsulfate Salt Of A Dipeptidyl Peptidase-Iv Inhibitor
|
|
AU2006306420A1
(en)
*
|
2005-10-25 |
2007-05-03 |
Merck Sharp & Dohme Corp. |
Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension
|
|
JP5356248B2
(ja)
|
2006-12-14 |
2013-12-04 |
テバ ファーマシューティカル インダストリーズ リミティド |
ラサギリンのタンニン酸塩
|
|
JP2011506442A
(ja)
*
|
2007-12-11 |
2011-03-03 |
コンジュケム バイオテクノロジーズ インコーポレイテッド |
インスリン分泌性ペプチド結合体の製剤
|
|
US8003672B2
(en)
*
|
2008-04-21 |
2011-08-23 |
Merck Sharp & Dohme Corp. |
CB-1 receptor modulator formulations
|
|
EP2218721A1
(en)
|
2009-02-11 |
2010-08-18 |
LEK Pharmaceuticals d.d. |
Novel salts of sitagliptin
|
|
US9211263B2
(en)
*
|
2012-01-06 |
2015-12-15 |
Elcelyx Therapeutics, Inc. |
Compositions and methods of treating metabolic disorders
|